Bottom line
Is LOGSX a good fund? The bottom line
LOGSX is a managed health care sector mutual fund from Oak Associates.
Annual fees run 1.04% — about $104 a year on every $10,000 invested, more expensive than 56% of health care sector funds we track.
It returned +19.6% over one year, +8.1% a year over five years, +7.3% a year over ten (as of Dec 31, 2025, per its prospectus).
With $56.1 million in net assets and 28 holdings, its largest position is N/a (6.9%) and the top 10 make up 51.8% of the portfolio.
What stands out
- 5-year return beat 95% of category peers
What to watch
- Concentrated: top 10 holdings are 51.8% of assets
Updated Nov 19, 2026
What LOGSX invests in
The Fund seeks long-term capital growth.
The Fund invests primarily in common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences. These health science companies include pharmaceutical firms, designers and manufacturers of medical equipment and supplies, operators of hospitals, other health-care services, and biotechnological researchers and developers. The Fund has adopted a policy to concentrate its investments (invest at least 25% of its assets) in companies doing business in the health science industry, but will regularly invest in health science companies well in excess of this amount. The Fund invests primarily in common stocks of U.S. companies, but may, to a lesser extent, invest in equity REITs, common stocks of foreign companies and American Depositary Receipts (ADRs) that meet the investment criteria of…
From the fund's prospectus (filed Feb 27, 2026).
LOGSX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| LOGSX | +19.6% | +8.1% | +7.3% |
| Health Care Sector median | +14.5% | +4.2% | +7.9% |
Source: Fund prospectus, as of Dec 31, 2025
What LOGSX costs
On a $10,000 investment, LOGSX's 1.04% expense ratio costs about $104 a year. The prospectus estimates $1,271 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.
LOGSX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | N/a | 6.91% |
| 2 | Cardinal Health Inc | 5.86% |
| 3 | Jazz Pharmaceuticals Plc | 5.77% |
| 4 | United Therapeutics Corp | 5.11% |
| 5 | Exelixis Inc | 4.95% |
| 6 | Amgen Inc | 4.86% |
| 7 | Lantheus Holdings Inc | 4.68% |
| 8 | Novartis Ag | 4.67% |
| 9 | Mckesson Corp | 4.53% |
| 10 | Cencora Inc | 4.46% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 51.8% of the fund. See all top 25 holdings and asset mix →